<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01936194</url>
  </required_header>
  <id_info>
    <org_study_id>6018</org_study_id>
    <nct_id>NCT01936194</nct_id>
  </id_info>
  <brief_title>The Effects of Polyunsaturated Fatty Acids (PUFA) on Allergic/Atopic Dermatitis</brief_title>
  <official_title>The Effects of Polyunsaturated Fatty Acids on Allergic/Atopic Dermatitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mead Johnson Nutrition</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>International Peace Maternity and Child Health Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Chinese Academy of Sciences</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Mead Johnson Nutrition</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This clinical trial will study the effects of PUFA supplementation during pregnancy and
      lactation period on fatty acid composition in human milk and plasma of the mothers and the
      clinical outcome of atopic dermatitis in infants at increased risk.
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Investigators don't want to conduct this study as time is limited.
  </why_stopped>
  <start_date>September 2013</start_date>
  <completion_date type="Actual">November 2014</completion_date>
  <primary_completion_date type="Actual">November 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Lipid Analysis</measure>
    <time_frame>Baseline, Delivery, Within one week after delivery, 6 weeks postpartum, 4 months postpartum</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Metabolomics Study of PUFA</measure>
    <time_frame>Baseline, Delivery, Within one week after delivery, 6 weeks postpartum, 4 months postpartum, 12 months postpartum</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Skin Prick Test to Common Allergens</measure>
    <time_frame>4 months postpartum, 12 months postpartum</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Clinical Assessment of IgE-mediated Allergic Eczema</measure>
    <time_frame>4 months postpartum, 12 months postpartum</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Fatty Acid Desaturase (FADS) Genotypes</measure>
    <time_frame>Baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>immunoglobulin E immunoglobulin E Immunoglobulin E (IgE) Antibodies</measure>
    <time_frame>Baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Immunological Biomarkers</measure>
    <time_frame>4 months postpartum, 12 months postpartum</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Medically-confirmed adverse events collected throughout the study period</measure>
    <time_frame>12 months postpartum</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Atopic Dermatitis</condition>
  <arm_group>
    <arm_group_label>Docosahexaenoic Acid (DHA)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>infants receiving capsule containing DHA.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High Olive Oil</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>infants receiving capsule without DHA and EPA.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>DHA+EPA</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>infants receiving capsule containing DHA and EPA.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>DHA+EPA</intervention_name>
    <arm_group_label>DHA+EPA</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>High Olive Oil</intervention_name>
    <arm_group_label>High Olive Oil</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>DHA</intervention_name>
    <arm_group_label>Docosahexaenoic Acid (DHA)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Woman is pregnant between 16 and 20 weeks

          -  Mother delivers after 36 weeks

          -  Mother is willing to breast-feed for four months

          -  Mother has potential to deliver a child with increased risk of atopic dermatitis

          -  Signed Informed Consent

        Exclusion Criteria:

          -  Mother is smoking

          -  Disease with influence on breast feeding

          -  Complicated pregnancy

          -  Allergic to seafood

          -  Allergic to soy

          -  Allergic to marine fish

          -  Mother has more than two salmon or tuna meals per week

          -  Mother is undergoing treatment with anticoagulants
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zhiwei Liu, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>International Peace Maternity and Child Health Hospital of China Welfare Institution</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Huiyong Yin, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chinese Academy of Sciences</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Bryan Liu, Ph.D.</last_name>
    <role>Study Director</role>
    <affiliation>Mead Johnson &amp; Company</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>International Peace Maternity and Child Health Hospital of China welfare Institute</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200030</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 27, 2013</study_first_submitted>
  <study_first_submitted_qc>September 2, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 5, 2013</study_first_posted>
  <last_update_submitted>September 15, 2016</last_update_submitted>
  <last_update_submitted_qc>September 15, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 16, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dermatitis</mesh_term>
    <mesh_term>Dermatitis, Atopic</mesh_term>
    <mesh_term>Eczema</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

